Subscribe to this column
Clifford A. Hudis, MD, FASCO, FACP
Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.
Mar 04, 2020
"Quality improvement happens slowly if you're in a silo": Dr. Jeffery Ward and I discuss the important updates to ASCO's alternative payment model for high-quality oncology care.
Feb 10, 2020
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus.
Feb 04, 2020
As we celebrate the 20th anniversary of World Cancer Day this February 4, it’s important to recognize that we are making progress in addressing cancer.
Jan 16, 2020
As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect, and need from the nation’s cancer care system.
Oct 16, 2019
Participants in ASCO's Advocacy Summit discuss the importance of being engaged with health policy to improve the lives of people affected by cancer.
Oct 04, 2019
About 42 million Medicaid patients do not have the guaranteed ability to participate in clinical trials.
Latest Blogs